Talk:2C-D/Archive 1: Difference between revisions
>Oskykins |
>Oskykins No edit summary |
||
Line 27: | Line 27: | ||
|} | |} | ||
'''2C-D''' ('''2,5-dimethoxy-4-methylphenethylamine''') is a synthetically produced [[psychoactive]] drug usually sold by online research chemical vendors. The substance itself is classed as a psychedelic [[Phenethylamines|phenethylamine]] of the [[2C-x]] family and was first synthesized in 1970 by a team from the Texas Research Institute of Mental Sciences[1]. | '''2C-D''' ('''2,5-dimethoxy-4-methylphenethylamine''') is a synthetically produced [[psychoactive]] drug usually sold by online research chemical vendors. The substance itself is classed as a psychedelic [[Phenethylamines|phenethylamine]] of the [[2C-x]] family and was first synthesized in 1970 by a team from the Texas Research Institute of Mental Sciences[1]. | ||
It was described and investigated in humans in Shulgin’s 1991 book [[PiHKAL]]: A Chemical Love Story. In his book, Shulgin lists the dosage range as being from 20 to 60 mg with many people recommending higher doses. The drug is used recreationally for its [[psychedelic]] and [[entactogenic]] effects. 2C-D has been explored as a potential [[nootropic]] in doses between 1-10mg. 2C-D is generally taken orally, though it may be insufflated. Insufflating tends to cause intense pain, however, and the dosage level is usually much lower. | It was described and investigated in humans in Shulgin’s 1991 book [[PiHKAL]]: A Chemical Love Story. In his book, Shulgin lists the dosage range as being from 20 to 60 mg with many people recommending higher doses. The drug is used recreationally for its [[psychedelic]] and [[entactogenic]] effects. 2C-D has been explored as a potential [[nootropic]] in doses between 1-10mg. 2C-D is generally taken orally, though it may be insufflated. Insufflating tends to cause intense pain, however, and the dosage level is usually much lower. | ||
=Chemistry= | |||
=Pharmacology= | |||
=Subjective effects= | =Subjective effects= | ||
Line 53: | Line 51: | ||
*'''[[Visual effects: Blank|Blank]]''' - | *'''[[Visual effects: Blank|Blank]]''' - | ||
=Toxicity and Harm Potential= | |||
===Lethal Dosage=== | ===Lethal Dosage=== | ||
Line 61: | Line 59: | ||
===Tolerance and Addiction Potential=== | ===Tolerance and Addiction Potential=== | ||
=Legal Issues= | |||
*'''United States:''' | *'''United States:''' | ||
Line 67: | Line 65: | ||
*'''United Kingdom:''' | *'''United Kingdom:''' | ||
=See Also= | |||
*[[Portal:Specific Substances|Specific Substances]] | *[[Portal:Specific Substances|Specific Substances]] | ||
=References= | |||
<references/> | <references/> |